Nama's AI scorecard currently rates Sonida Senior Living Sell (2.1 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

When does SNDA report earnings?

Sonida Senior Living's next scheduled report is on Mar 8, 2027. Analysts expect EPS of -$0.47.

What is the SNDA price target?

The median analyst price target from 6 analysts is $47.50, with a range of $43.00 – $65.00.

Is SNDA Shariah compliant?

Nama's AAOIFI-style screen reads Sonida Senior Living as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Nama Insights

Sonida Senior Living (SNDA)

Healthcare · Medical Care Facilities · NYSE

Sonida Senior Living (SNDA) is a Healthcare company in the Medical Care Facilities industry. It has a market capitalization of $1.58B and a free-cash-flow yield of -1.5%. Over the most recent reported fiscal year, revenue grew 25.2%. Nama's AI scorecard rates it Sell, 2.1 out of 10. On 12-month momentum it ranks in the middle band of its market.

AI scorecard

Sell · 2.1/10

Clearly negative, short of the bottom band. As of Nov 7, 2026.

Momentum

Middle · +16.1% over 12 months ex. last

Middle fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-26.1%

How far the last close sits under the highest price of the past five years.

Market cap	$1.58B
Trailing P/E	—
Price / book	1.8
Price / sales	3.3
FCF yield	-1.5%
Dividend yield	—
Gross margin	87.8%
Operating margin	-2.5%
Net margin	-23.3%
Revenue growth (YoY)	+25.2%
Revenue growth (3-yr annual)	+16.9%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Beta	0.7
Exchange	NYSE
Sector	Healthcare
Industry	Medical Care Facilities

SNDA earnings

Next report: Mar 8, 2027 (Q4 2026, EPS estimate -$0.47). Beat the EPS estimate in 1 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 5, 2026	-$0.41	-$0.50	+18.0%	—
Q2 2026	Aug 10, 2026	-$0.52	-$0.48	-8.3%	$207.65M
Q1 2026	May 11, 2026	-$2.39	-$1.46	-63.7%	$122.63M
Q4 2025	Mar 11, 2026	-$1.72	-$1.30	-32.3%	$97.66M

SNDA analyst price target

Median target $47.50 from 6 analysts, ranging $43.00 – $65.00.

Medical Care Facilities peers

Ticker	Company	Market cap	P/E
HCA	HCA Healthcare	$103.40B	16.5
THC	Tenet Healthcare	$22.55B	12.7
EHC	Encompass Health	$13.50B	22.4
FMS	Fresenius Medical Care	$12.15B	10.2
DVA	DaVita	$12.04B	13.6
UHS	Universal Health Services	$11.52B	8.6
ENSG	Ensign Group	$10.56B	23.8
PACS	PACS Group	$7.87B	20.1

Explore live SNDA data on Nama Insights →

Recent Congressional trades

Sonida Senior Living trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Rick Larsen	House	Sell	$1,001 - $15,000	Apr 15, 2026
Rick Larsen	House	Exchange	$1,001 - $15,000	Apr 15, 2026

SNDA FAQ

Is SNDA a buy?: Nama's AI scorecard currently rates Sonida Senior Living Sell (2.1 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
When does SNDA report earnings?: Sonida Senior Living's next scheduled report is on Mar 8, 2027. Analysts expect EPS of -$0.47.
What is the SNDA price target?: The median analyst price target from 6 analysts is $47.50, with a range of $43.00 – $65.00.
Is SNDA Shariah compliant?: Nama's AAOIFI-style screen reads Sonida Senior Living as Not Shariah Compliant. At least one of the three ratios or the industry test failed.